# Clinical Trial Variable Dictionary

| Variable Name              | Type       | Range/Values                                                             | Distribution/Percentage                        | Description                                                                 |
|---------------------------|------------|---------------------------------------------------------------------------|------------------------------------------------|-----------------------------------------------------------------------------|
| `PatientID`               | String     | FBC_001 to FBC_100                                                        | Sequential                                     | Unique identifier for each patient.                                        |
| `Age`                     | Integer    | 18–70                                                                     |18-30,5%;31-40,15%;41-50,30%;51-60,35%;61-70,15%| Age in years; inclusion criteria.                                          |
| `Height`                  | Float      | 140–190 cm                                                                | Normal(μ=160, σ=7)                             | Typical adult female height; mean = 160, SD = 7.                           |
| `Weight`                  | Float      | 40–120 kg                                                                 | Normal(μ=65, σ=15)                             | Typical adult female weight; mean = 65, SD = 15.                           |
| `Ethnicity`               | Enum       | Asian, Black, White, Hispanic, Other                                      | [7%, 15%, 60%, 15%, 3%]                        | Self-reported ethnicity.                                                   |
| `Diagnosis`               | String     | early-stage, Locally advanced, Recurrent, Metastatic, Reccurent metastatic| [40%, 20%, 15%, 15%, 10%]                      | Disease classification (e.g., recurrent, metastatic).                      |
| `ECOG`                    | Integer    | 0–2                                                                       | [50%, 35%, 15%]                                | Performance status score (0 = fully active, 2 = limited self-care).        |
| `CNS_Lesion_Count`        | Integer    | 0, 1-5, 6-10, 11-30                                                       | [70%, 25%, 4%, 1%]                             | Number of brain/CNS lesions.                                               |
| `CNS_Lesion_Status`       | Categorical| Untreated, Stable, Progressing, Responding, Resolved.                     | [30%, 40%, 20%, 5%, 5%]                        | Lesion progression status from MRI.                                        |
| `HER2_Status`             | Categorical| Positive, Negative                                                        | [20%, 80%]                                     | HER2 receptor status; affects treatment decisions.                         |
| `ER_Status`               | Categorical| Positive, Negative                                                        | [75%, 25%]                                     | Estrogen receptor status.                                                  |
| `PR_Status`               | Categorical| Positive, Negative                                                        | [65%, 35%]                                     | Progesterone receptor status.                                              |
| `Menopausal_Status`       | Categorical| Premenopausal, Postmenopausal                                             | Conditional on Age: 0%, 5%,40%,80%,100%       | Affects endocrine therapy planning.                                        |
| `Tumor_Size`              | Float      | 0.1 – 10 cm                                                               | LogNormal(μ=1.5, σ=0.8)                        | Tumor size in centimeters; log-normal distribution.                        |
| `TNM_Stage`               | Categorical| I, IIA, IIB, III, IV                                                      | [15%, 25%, 30%, 20%, 10%]                      | Clinical cancer staging (I=early, II=local, III=advanced, IV=metastatic).  |
| `Comorbidity_Indicator`   | Boolean    | True, False                                                               | [35%, 65%]                                     | Indicates significant comorbidities.                                       |
| `Prior_HER2_Therapy`      | Boolean    | True, False       Conditional on HER2_Status:                             | HER2_Positive :70% True, otherwise: False      | Whether prior anti-HER2 therapy was received.                              |
| `Prior_TKI_Therapy`       | Boolean    | True, False       Conditional on HER2_Status:                             | HER2_Positive:35% True, otherewise: False      | Indicates prior tyrosine kinase inhibitor treatment.                       |
| `Last_Treatment_Interval_Weeks`|Integer| 4–6,7-9,10-12,13-20                                                       | [40%, 35%, 15%, 10%]                           | Number of weeks since last treatment.                                      |
| `Toxicity_Grade`          | Integer    | 0, 1                                                                      | [70%, 30%]                                     | Grade of toxicity from prior treatments.                                   |
| `WBC`                     | Float      | ≥3.0 ×10⁹/L                                                               | Normal(μ=6.5, σ=1.5)                           | White blood cell count; eligibility threshold.                             |
| `ANC`                     | Float      | ≥1.5 ×10⁹/L                                                               | Normal(μ=3.5, σ=1.0)                           | Absolute neutrophil count; must meet minimum.                              |
| `PLT`                     | Float      | ≥100 ×10⁹/L                                                               | Normal(μ=250, σ=50)                            | Platelet count; part of hematologic assessment.                            |
| `Hemoglobin`              | Float      | ≥9.0 g/dL                                                                 | Normal(μ=13.5, σ=1.5)                          | Must meet minimum hemoglobin threshold.                                    |
| `TBIL`                    | Float      | ≤2.5 × ULN                                                                | LogNormal(μ=0.8, σ=0.4)                        | Total bilirubin; used to evaluate liver function.                          |  
| `ALT`                     | Float      | ≤2.5 × ULN (or 5 if liver mets)                                           | LogNormal(μ=25, σ=15)                          | Alanine aminotransferase; liver enzyme.                                    |
| `AST`                     | Float      | ≤2.5 × ULN (or 5 if liver mets)                                           | LogNormal(μ=30, σ=18)                          | Aspartate aminotransferase; another liver function marker.                 |
| `Creatinine_Clearance`    | Float      | ≥60 ml/min                                                                | LogNormal(μ=85, σ=20)                          | Kidney function measurement (eGFR/CrCl).                                   |
| `Life_Expectancy_Weeks`   | Integer    | 12-24, 25-52, 53-104, 105-156                                             | 35%,35%,20%,10%                                | Expected survival time; minimum required for enrollment.                   |
